Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Current Topics in Microbiology and Immunology|February 19, 2022
Human Challenge Studies with Coronaviruses Old and NewRichard McKendry, Nana-Marie Lemm, Loukas Papargyris, et al.
Frontiers in Immunology|October 24, 2022
Comparison of blood and lymph node cells after intramuscular injection with HIV envelope immunogensSuzanne Day, Charandeep Kaur, Hannah M Cheeseman, et al.
The Journal of Infectious Diseases|June 27, 2022
Wearable Sensor-Based Detection of Influenza in Presymptomatic and Asymptomatic IndividualsDorota S Temple, Meghan Hegarty-Craver, Robert D Furberg, et al.
Science Immunology|February 9, 2024
Mucosal and systemic immune correlates of viral control after SARS-CoV-2 infection challenge in seronegative adultsHelen R Wagstaffe, Ryan S Thwaites, Arnold Reynaldi, et al.
Clinical and Translational Science|October 20, 2021
Incidental findings in UK healthy volunteers screened for a COVID-19 vaccine trialSusanne H Hodgson, Poppy Iveson, Jessica Larwood, et al.
Ebiomedicine|January 3, 2025
Experimental medicine study with stabilised native-like HIV-1 Env immunogens drives long-term antibody responses, but lacks neutralising breadthKatrina M Pollock, Hannah M Cheeseman, Leon R McFarlane, et al.
British Journal of Clinical Pharmacology|November 28, 2022
The effect of TRV027 on coagulation in COVID-19: A pilot randomized, placebo-controlled trialAlexander J Robbins, Nur Amalina Che Bakri, Edward Toke-Bjolgerud, et al.
The Lancet. Infectious Diseases|April 14, 2024
An investigation of trachoma vaccine regimens by the chlamydia vaccine CTH522 administered with cationic liposomes in healthy adults (CHLM-02): a phase 1, double-blind trialKatrina M Pollock, Álvaro H Borges, Hannah M Cheeseman, et al.
Nature Communications|December 7, 2025
Pre-existing and early cellular immune factors correlate with functionally complete protection against primary controlled human SARS-CoV-2 infectionHelen R Wagstaffe, Ryan S Thwaites, Jasmin K Sidhu, et al.
Eclinicalmedicine|January 19, 2022
Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trialKatrina M Pollock, Hannah M Cheeseman, Alexander J Szubert, et al.
Pageof 1